Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.40
Ask:
4.00
Spread: 0.60 (17.647%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Bushveld Convertible Loan Note Update

14 Jul 2023 16:00

RNS Number : 1240G
Primorus Investments PLC
14 July 2023
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Bushveld Convertible Loan Note Update

 

14 July 2023

 

Further to its announcement of 29 March 2022, Primorus Investments plc (AIM: PRIM) announces that the Company and Bushveld Minerals Limited ("BMN") have agreed in principle, subject to contract, to alter the terms of the convertible loan note ("BCLN") held by the Company in BMN.

 

Details of the BCLN were first announced by the Company on 19 January 2022 which included a maturity date of 14 July 2023 ("Maturity Date"). On 6 April and 26 April 2022, BMN announced that the Company had exercised its rights under the BCLN with BMN and converted a total of £411,000 of the BCLN into 4,157,645 new ordinary shares in BMN ("BMN Shares"). The Company disposed of the BMN Shares for approximately £432,000.

 

As at the Maturity Date, the total principal amount and accrued interest of the outstanding BCLN is approximately £910,000.

 

Following the lapse of the Maturity Date, BMN and the Company have agreed in principle, subject to contract, to vary the terms of repayment such that BMN will make the repayment in cash as opposed to shares on the following terms:

 

· The outstanding balance shall bear interest at the annual rate of 10%

· Initial payment of USD$150,000 by BMN, followed by payments of USD$125,000 to the Company every two weeks, with the final payment to be received prior to the 30 November 2023.

 

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's announcement of 19 January 2023.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors are responsible for the release of this announcement.

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson/James Caithie

 

+44 (0) 20 7213 0880

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURKZGMNDDNGFZM
Date   Source Headline
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement
20th Sep 20247:00 amRNSFurther Investment in Fresho Pty Ltd
5th Sep 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.